Skip to main content
photo_81092_landscape_650x433.jpg

How Philanthropy Can Help Community Development Survive Trump

Donald Trump will not be president forever, but in his time in office he can do substantial damage in many areas of American life. As one donor told us, “We risk having 40 years of progress in community development unraveled in the next 18 months.”

Principally, that’s because the new administration, along with Republican congressional leaders, is targeting federal spending on social programs and community development — a major bulwark against the consequences of generational poverty and ever-growing wealth inequality. Hundreds of billions of dollars are at risk.

Philanthropy, which awards about $60 billion in grants annually, cannot possibly meet this shortfall. But it can help ensure that when the political winds change, as they inevitably will, the pieces are in place for a progressive agenda. One key way to do this is to support innovative local and regional programs that can be expanded nationally when the opening occurs.

Read the full article in The Chronicle of Philanthropy 

Publication date: 2017-03-14
Parent publication: The Chronicle of Philanthropy
Publication URL: How Philanthropy Can Help Community Development Survive Trump

More related work

March 19, 2020
Default Image

Protect the vulnerable, advance the democratic economy: Our statement on the COVID-19 crisis

We are in a period of breakdown, in which all that is wrong with the current system is now being laid bare. Rather than rebuild what we now clearly see should never have been, we must lead the construction out of this crisis of something new.

read more
March 18, 2020
Default Image

HAN Public Comments on Fair Housing Act Proposed Changes

The Healthcare Anchor Network submitted public comments to the Department of Housing and Urban Development (HUD), expressing our opposition to HUD’s proposed changes to the 2015 Affirmatively Furthering Fair Housing rule.

read more
March 17, 2020
An array of prescription medications on shelves

Online press briefing: Vaccines—The COVID-19 Case for Public Pharmaceutical Research and Development

Leading experts believe that it is the government’s responsibility to ensure widespread access to safe and effective vaccines that are developed with taxpayer money. In this virtual press briefing, hear why the U.S. government should develop and manufacture vaccines and other essential medicines so that we get the medicines we need, when we need them and at prices we can afford.

read more